2021
DOI: 10.1016/s2352-4642(21)00159-0
|View full text |Cite
|
Sign up to set email alerts
|

Paediatric non-rhabdomyosarcoma soft tissue sarcomas: the prospective NRSTS 2005 study by the European Pediatric Soft Tissue Sarcoma Study Group (EpSSG)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
95
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

6
3

Authors

Journals

citations
Cited by 40 publications
(99 citation statements)
references
References 39 publications
3
95
0
1
Order By: Relevance
“…In the light of the results of the EpSSG NRSTS 2005 study, 19 current EpSSG recommendations divide patients into four treatment groups based on surgical stage according to the Intergroup Rhabdomyosarcoma Study (IRS) classification, tumor size, nodal involvement, and histopathological tumor grade (tumor site is added as a criterion for synovial sarcoma). ( Figure 1 )
Figure 1 EpSSG standard-risk stratification and treatment recommendations for local/locoregional adult-type NRSTS (including synovial sarcoma).
…”
Section: Treatment Recommendations Applicable To Adult-type Nrsts In ...mentioning
confidence: 99%
See 1 more Smart Citation
“…In the light of the results of the EpSSG NRSTS 2005 study, 19 current EpSSG recommendations divide patients into four treatment groups based on surgical stage according to the Intergroup Rhabdomyosarcoma Study (IRS) classification, tumor size, nodal involvement, and histopathological tumor grade (tumor site is added as a criterion for synovial sarcoma). ( Figure 1 )
Figure 1 EpSSG standard-risk stratification and treatment recommendations for local/locoregional adult-type NRSTS (including synovial sarcoma).
…”
Section: Treatment Recommendations Applicable To Adult-type Nrsts In ...mentioning
confidence: 99%
“…It was conducted from 2005 to 2016, and involved 100 academic centers and hospitals in 14 different countries. 19 In terms of rationale, patient stratification and treatment paradigms (based on both pediatric and adult experiences), the EpSSG NRSTS 2005 study was very similar to the ARST0332 study developed by the North-American Soft Tissue Sarcoma Committee of the Children’s Oncology Group (COG), conducted from 2007 to 2012. 20 …”
Section: Introductionmentioning
confidence: 99%
“…In summary, patients with initially unresectable SS treated according to CWS recommendations have a good prognosis and compare with those of other series (Venkatramani et al 2021;Ferrari et al 2021). To our knowledge this analysis represents the largest series of initially unresectable SS treated in prospective risk-adapted trials so far.…”
Section: Discussionmentioning
confidence: 93%
“…The analysis was based on all patients registered within the EpSSG NRSTS05 trial (from August 2005 to December 2016; European Union Drug Regulating Authorities Clinical Trials (EUDRACT) No. 2005‐001139‐31 5 ) and the EpSSG MTS2008 study (open from June 2010 to December 2016). The EpSSG MTS2008 protocol (NCT00379457) was a prospective, observational, single‐arm study dedicated to pediatric and young adults with metastatic sarcomas 6 …”
Section: Methodsmentioning
confidence: 99%